Company intelligence / Profile preview

Iris Statistical Computing

Ownership: Private
Employees: ~10
Development stage: Other

Overview

Iris Statistical Computing is a specialized consulting firm serving small to mid-size biotech and pharmaceutical companies. The company focuses on ensuring quality and timely FDA data submission filings for New Drug Applications (NDAs) and Biologics License Applications (BLAs). Their expertise includes statistical analysis, CDISC data package evaluation, sample size estimation, multiple hypothesis testing, interim analyses, non-inferiority testing, and related regulatory writing. Founded by Lisa Brooks in 2007, the firm uses proprietary checklists and processes to evaluate submission readiness[1][3][7].

Industry: Consulting

Beyond the preview

Go deeper on Iris Statistical Computing.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Iris Statistical Computing.

Explore the full profile